This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Eberhard-Karls-Universitaet Tuebingen Universitaetsklinikum. Active years: 2010.
Company Filing History:
Years Active: 2010
Title: Sigrid Hojak: Innovator in Monoclonal Antibody Research
Introduction
Sigrid Hojak is a notable inventor based in Berlin, Germany. She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. Her work focuses on the Frizzled receptor family, which plays a crucial role in various biological processes.
Latest Patents
Sigrid Hojak holds a patent for a monoclonal antibody against the Frizzled receptor 4. This invention relates to a monoclonal antibody or fragment that specifically binds to human receptors of the Frizzled (FZD) family. The patent also includes a hybridoma cell that produces the antibody. Additionally, it outlines methods for detecting and isolating FZD family receptors in biological samples. The invention further describes the use of the antibody for specific detection and isolation of these receptors, along with a composition and kit that includes the monoclonal antibody.
Career Highlights
Throughout her career, Sigrid Hojak has worked at prestigious institutions, including Eberhard-Karls-Universität Tübingen and Universitätsklinikum Tübingen. Her research has contributed to advancements in understanding the Frizzled receptor family and its implications in health and disease.
Collaborations
Sigrid has collaborated with notable colleagues such as Hans-Joerg Buehring and Ingrid Albert. These collaborations have enhanced her research and expanded the impact of her work in the scientific community.
Conclusion
Sigrid Hojak's innovative work in monoclonal antibody research exemplifies the importance of scientific advancements in medicine. Her contributions continue to influence the field and pave the way for future discoveries.